319 related articles for article (PubMed ID: 14678722)
21. Systemic antifungal therapy for tinea capitis in children.
González U; Seaton T; Bergus G; Jacobson J; Martínez-Monzón C
Cochrane Database Syst Rev; 2007 Oct; (4):CD004685. PubMed ID: 17943825
[TBL] [Abstract][Full Text] [Related]
22. Blad-containing oligomer: a novel fungicide used in crop protection as an alternative treatment for tinea pedis and tinea versicolor.
Carreira A; Ferreira JB; Pereira I; Ferreira J; Filipe P; Ferreira RB; Monteiro S
J Med Microbiol; 2018 Feb; 67(2):198-207. PubMed ID: 29388537
[TBL] [Abstract][Full Text] [Related]
23. A risk-benefit assessment of the newer oral antifungal agents used to treat onychomycosis.
Gupta AK; Shear NH
Drug Saf; 2000 Jan; 22(1):33-52. PubMed ID: 10647975
[TBL] [Abstract][Full Text] [Related]
24. Management of mycoses in daily practice.
Drago L; Micali G; Papini M; Piraccini BM; Veraldi S
G Ital Dermatol Venereol; 2017 Dec; 152(6):642-650. PubMed ID: 29050446
[TBL] [Abstract][Full Text] [Related]
25. Treatment of superficial fungal infections of the skin.
Pettit JH
Drugs; 1975; 10(2):130-42. PubMed ID: 126144
[No Abstract] [Full Text] [Related]
26. Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States.
Gupta AK
J Am Acad Dermatol; 2000 Oct; 43(4 Suppl):S81-95. PubMed ID: 11051137
[TBL] [Abstract][Full Text] [Related]
27. Beyond spaghetti and meatballs: skin diseases associated with the Malassezia yeasts.
Levin NA
Dermatol Nurs; 2009; 21(1):7-13, 51; quiz 14. PubMed ID: 19283956
[TBL] [Abstract][Full Text] [Related]
28. Humoral immunity to Malassezia furfur serovars A, B and C in patients with pityriasis versicolor, seborrheic dermatitis and controls.
Ashbee HR; Fruin A; Holland KT; Cunliffe WJ; Ingham E
Exp Dermatol; 1994 Oct; 3(5):227-33. PubMed ID: 7881768
[TBL] [Abstract][Full Text] [Related]
29. The evolving role of itraconazole, fluconazole and terbinafine in the treatment of tinea capitis.
Friedlander SF
Pediatr Infect Dis J; 1999 Feb; 18(2):205-10. PubMed ID: 10048703
[TBL] [Abstract][Full Text] [Related]
30. Tinea capitis.
Gupta AK; Summerbell RC
Med Mycol; 2000 Aug; 38(4):255-87. PubMed ID: 10975696
[TBL] [Abstract][Full Text] [Related]
31. [Malassezia yeasts and their significance in dermatology].
Hort W; Nilles M; Mayser P
Hautarzt; 2006 Jul; 57(7):633-43; quiz 644-5. PubMed ID: 16758222
[TBL] [Abstract][Full Text] [Related]
32. [Malassezia related diseases].
Sei Y
Nihon Ishinkin Gakkai Zasshi; 2006; 47(2):75-80. PubMed ID: 16699486
[TBL] [Abstract][Full Text] [Related]
33. Pityriasis versicolor.
Gupta AK; Bluhm R; Summerbell R
J Eur Acad Dermatol Venereol; 2002 Jan; 16(1):19-33. PubMed ID: 11952286
[TBL] [Abstract][Full Text] [Related]
34. Pityriasis versicolor: an update on pharmacological treatment options.
Gupta AK; Lyons DC
Expert Opin Pharmacother; 2014 Aug; 15(12):1707-13. PubMed ID: 24991691
[TBL] [Abstract][Full Text] [Related]
35. Update in antifungal therapy of dermatophytosis.
Gupta AK; Cooper EA
Mycopathologia; 2008; 166(5-6):353-67. PubMed ID: 18478357
[TBL] [Abstract][Full Text] [Related]
36. Evidence-based Danish guidelines for the treatment of Malassezia-related skin diseases.
Hald M; Arendrup MC; Svejgaard EL; Lindskov R; Foged EK; Saunte DM;
Acta Derm Venereol; 2015 Jan; 95(1):12-9. PubMed ID: 24556907
[TBL] [Abstract][Full Text] [Related]
37. Malassezia infections: a medical conundrum.
Pedrosa AF; Lisboa C; Gonçalves Rodrigues A
J Am Acad Dermatol; 2014 Jul; 71(1):170-6. PubMed ID: 24569116
[TBL] [Abstract][Full Text] [Related]
38. Tinea capitis in children: a systematic review of management.
Gupta AK; Mays RR; Versteeg SG; Piraccini BM; Shear NH; Piguet V; Tosti A; Friedlander SF
J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2264-2274. PubMed ID: 29797669
[TBL] [Abstract][Full Text] [Related]
39. Common superficial fungal infections in patients with AIDS.
Aly R; Berger T
Clin Infect Dis; 1996 May; 22 Suppl 2():S128-32. PubMed ID: 8722840
[TBL] [Abstract][Full Text] [Related]
40. [Tinea capitis. Therapeutic options in the post-griseofulvin era].
Möhrenschlager M; Korting HC; Seidl HP; Ring J; Abeck D
Hautarzt; 2002 Dec; 53(12):788-94. PubMed ID: 12444518
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
